BERDINI, Valerio,BUCK, Ildiko Maria,DAY, James Edward Harvey,GRIFFITHS-JONES, Charlotte Mary,HEIGHTMAN, Thomas Daniel,HOWARD, Steven,MURRAY, Christopher William,NORTON, David,O'REILLY, Marc,WOOLFORD,,OREILLY, Marc,WOOLFORD, A
申请号：
PH12018500792
公开号：
PH12018500792A1
申请日:
2018.04.12
申请国别(地区):
PH
年份:
2018
代理人:
摘要：
The invention provides a compound of formula (0): or a pharmaceutically acceptable salt, N-oxide or tautomer thereof. The compounds are inhibitors of ERK 1/2 kinases and will be useful in the treatment of ERKl/2-mediated conditions. The compounds are therefore useful in therapy, in particular in the treatment of cancer.
